.@AdialPharma CEO Cary Claiborne was in Washington, D.C., meeting with House and Senate offices, including @bmhsudtf leadership. Conversations focused on behavioral health policy priorities and the need for evidence-based options for people living with Alcohol Use Disorder (#AUD).
$ADIL #MentalHealth #AlcoholUseDisorder #BehavioralHealth #PublicPolicy
New research from @YaleMed referencing the @NIH shows higher drinking frequency is linked to lower synaptic density in people with Alcohol Use Disorder (#AUD).
Using PET imaging, researchers found reduced neural connections in regions tied to memory, reward, and decision-making, reinforcing AUD as a brain-based condition.
Read the report here: https://t.co/HMe8RGsdPK
Explore the full study on @NLM_NIH: https://t.co/k26im7JTqN
#AlcoholUseDisorder #BrainHealth
.@AdialPharma commands the introduction of H.R. 7091, bipartisan legislation expanding research into emerging therapies for #AUD for veterans. The bill supports investigational treatments aligned with evolving federal recovery standards, including non-abstinence, harm reduction approaches.
For more: https://t.co/92k6VZiJd4
$ADIL #VeteransHealth #HealthPolicy #Biotech #AddictionTreatment